BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 22975593)

  • 1. Oncoepigenomics: making histone lysine methylation count.
    Decarlo D; Hadden MK
    Eur J Med Chem; 2012 Oct; 56():179-94. PubMed ID: 22975593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting histone lysine methylation in cancer.
    McGrath J; Trojer P
    Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
    Krishnan S; Horowitz S; Trievel RC
    Chembiochem; 2011 Jan; 12(2):254-63. PubMed ID: 21243713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
    Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
    ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone lysine methylation dynamics: establishment, regulation, and biological impact.
    Black JC; Van Rechem C; Whetstine JR
    Mol Cell; 2012 Nov; 48(4):491-507. PubMed ID: 23200123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the impact of gene variants on histone lysine methylation.
    Van Rechem C; Whetstine JR
    Biochim Biophys Acta; 2014 Dec; 1839(12):1463-76. PubMed ID: 24859469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for substrate recognition by lysine methyltransferases and demethylases.
    Del Rizzo PA; Trievel RC
    Biochim Biophys Acta; 2014 Dec; 1839(12):1404-15. PubMed ID: 24946978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone lysine demethylases: emerging roles in development, physiology and disease.
    Shi Y
    Nat Rev Genet; 2007 Nov; 8(11):829-33. PubMed ID: 17909537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
    Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
    J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the epigenetic mechanisms involving histone lysine methylation and demethylation in ischemia induced damage and repair has therapeutic implication.
    Chakravarty S; Jhelum P; Bhat UA; Rajan WD; Maitra S; Pathak SS; Patel AB; Kumar A
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):152-164. PubMed ID: 27664837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine methylation: beyond histones.
    Zhang X; Wen H; Shi X
    Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):14-27. PubMed ID: 22194010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future therapeutic potential of histone demethylases: A critical analysis.
    Natoli G; Testa G; De Santa F
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.
    Wang Z; Patel DJ
    Q Rev Biophys; 2013 Nov; 46(4):349-73. PubMed ID: 23991894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.
    Tian X; Zhang S; Liu HM; Zhang YB; Blair CA; Mercola D; Sassone-Corsi P; Zi X
    Curr Cancer Drug Targets; 2013 Jun; 13(5):558-79. PubMed ID: 23713993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins.
    Rathert P; Dhayalan A; Ma H; Jeltsch A
    Mol Biosyst; 2008 Dec; 4(12):1186-90. PubMed ID: 19396382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Writing, erasing and reading histone lysine methylations.
    Hyun K; Jeon J; Park K; Kim J
    Exp Mol Med; 2017 Apr; 49(4):e324. PubMed ID: 28450737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders of histone methylation: Molecular basis and clinical syndromes.
    Al Ojaimi M; Banimortada BJ; Othman A; Riedhammer KM; Almannai M; El-Hattab AW
    Clin Genet; 2022 Sep; 102(3):169-181. PubMed ID: 35713103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SnapShot: Histone-modifying enzymes.
    Kouzarides T
    Cell; 2007 Nov; 131(4):822. PubMed ID: 18022374
    [No Abstract]   [Full Text] [Related]  

  • 20. A systematic evaluation of the compatibility of histones containing methyl-lysine analogues with biochemical reactions.
    Jia G; Wang W; Li H; Mao Z; Cai G; Sun J; Wu H; Xu M; Yang P; Yuan W; Chen S; Zhu B
    Cell Res; 2009 Oct; 19(10):1217-20. PubMed ID: 19770845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.